Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03405792
Brief Title: Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP) (2-THE-TOP)

First Submitted : January 12, 2018
First Submitted that Met QC Criteria : January 19, 2018
First Posted : January 23, 2018

Last Update Submitted that Met QC Criteria : January 14, 2019
Last Update Posted : January 16, 2019